Louisiana State Employees Retirement System Vertex Pharmaceuticals Inc Transaction History

Louisiana State Employees Retirement System

$5.77 Billion
Q3 2025

A detailed history of Louisiana State Employees Retirement System transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 32,200 shares of VRTX stock, worth $14 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

32,200

Previous 32,300 0.31%

Holding current value

$14 Million

Previous $14.4 Million 12.3%

% of portfolio

0.22%

Previous 0.27%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 22, 2025	SELL	$366.54 - $479.53 $36,654 - $47,953	-100 Reduced 0.31%	32,200 $12.6 Million
Q2 2025 Jul 23, 2025	SELL	$421.16 - $509.5 $126,348 - $152,850	-300 Reduced 0.92%	32,300 $14.4 Million
Q1 2025 May 01, 2025	SELL	$402.49 - $513.76 $40,249 - $51,376	-100 Reduced 0.31%	32,600 $15.8 Million
Q4 2024 Jan 29, 2025	SELL	$396.64 - $516.74 $594,960 - $775,110	-1,500 Reduced 4.39%	32,700 $13.2 Million
Q3 2024 Oct 23, 2024	SELL	$460.0 - $505.78 $414,000 - $455,202	-900 Reduced 2.56%	34,200 $15.9 Million

Q2 2024 Jul 24, 2024	SELL	$392.81 - $485.53 $78,562 - $97,106	-200 Reduced 0.57%	35,100 $16.5 Million
Q1 2024 Apr 23, 2024	SELL	$407.69 - $446.08 $326,152 - $356,864	-800 Reduced 2.22%	35,300 $14.8 Million
Q4 2023 Jan 29, 2024	SELL	$343.0 - $410.68 $102,900 - $123,204	-300 Reduced 0.82%	36,100 $14.7 Million
Q3 2023 Oct 17, 2023	BUY	$338.18 - $362.46 $1.49 Million - $1.59 Million	4,400 Added 13.75%	36,400 $12.7 Million
Q2 2023 Jul 18, 2023	BUY	$314.42 - $351.91 $786,050 - $879,775	2,500 Added 8.47%	32,000 $11.3 Million
Q1 2023 Apr 19, 2023	BUY	$283.23 - $323.1 $28,323 - $32,310	100 Added 0.34%	29,500 $9.29 Million
Q4 2022 Jan 24, 2023	SELL	$285.76 - $321.48 $228,608 - $257,184	-800 Reduced 2.65%	29,400 $8.49 Million
Q3 2022 Oct 19, 2022	BUY	$273.83 - $305.53 $82,149 - $91,658	300 Added 1.0%	30,200 $8.74 Million
Q2 2022 Jul 20, 2022	BUY	$234.96 - $292.55 $46,992 - $58,510	200 Added 0.67%	29,900 $8.66 Million
Q1 2022 Apr 22, 2022	BUY	$221.42 - $260.97 $66,426 - $78,291	300 Added 1.02%	29,700 $8.47 Million
Q4 2021 Jan 14, 2022	SELL	$177.01 - $223.45 $17,701 - $22,345	-100 Reduced 0.34%	29,400 $6.46 Million
Q1 2021 Apr 14, 2021	BUY	$207.02 - $241.31 $414,040 - $482,620	2,000 Added 7.27%	29,500 $6.34 Million
Q4 2020 Jan 11, 2021	BUY	$207.01 - $276.09 $2.96 Million - $3.95 Million	14,300 Added 108.33%	27,500 $6.5 Million
Q3 2020 Oct 19, 2020	BUY	$255.65 - $303.1 $536,865 - $636,510	2,100 Added 18.92%	13,200 $3.59 Million
Q2 2020 Jul 13, 2020	BUY	$225.48 - $295.8 $45,096 - $59,160	200 Added 1.83%	11,100 $3.22 Million
Q1 2020 Apr 13, 2020	SELL	$199.77 - $247.81 $259,701 - $322,153	-1,300 Reduced 10.66%	10,900 $2.59 Million
Q4 2019 Jan 17, 2020	SELL	$166.71 - $223.91 $33,342 - $44,782	-200 Reduced 1.61%	12,200 $2.67 Million
Q3 2019 Oct 24, 2019	SELL	$166.23 - $187.09 $66,492 - $74,836	-400 Reduced 3.13%	12,400 $2.1 Million
Q2 2019 Jul 15, 2019	SELL	$164.61 - $190.37 $115,227 - $133,259	-700 Reduced 5.19%	12,800 $2.25 Million
Q1 2019 Apr 15, 2019	BUY	$163.73 - $194.7 $16,372 - $19,470	100 Added 0.75%	13,500 $2.48 Million
Q4 2018 Jan 14, 2019	SELL	$151.91 - $192.21 $243,056 - $307,536	-1,600 Reduced 10.67%	13,400 $2.22 Million
Q2 2018 Jul 18, 2018	SELL	$145.72 - $169.96 $72,860 - $84,980	-500 Reduced 3.23%	15,000 $2.55 Million
Q1 2018 Apr 18, 2018	BUY	$151.6 - $177.13 $30,320 - $35,426	200 Added 1.31%	15,500 $2.53 Million
Q4 2017 Jan 16, 2018	SELL	$137.28 - $155.55 $54,912 - $62,220	-400 Reduced 2.55%	15,300 $2.29 Million
Q3 2017 Oct 16, 2017	BUY	$148.13 - $162.24 $2.33 Million - $2.55 Million	15,700	15,700 $2.39 Million

Others Institutions Holding VRTX

# of Institutions

1,786

Shares Held

231M

Call Options Held

1.83M

Put Options Held

1.21M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $111B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.

Account

Louisiana State Employees Retirement System Vertex Pharmaceuticals Inc Transaction History